Of the 47 pregnant study participants, most were vaccinated and only two stopped taking nirmatrelvir and ritonavir because of side effects, according to a study published Nov. 29 in JAMA.
There were no reported complications with the drug combination, but there was a higher prevalence of cesarean section deliveries than expected. After taking the two drugs, 12 study participants had C-sections, nine of which were planned.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
